No black box warning on record for Acyclovir Sodium

As of the latest FDA labeling reviewed, Acyclovir Sodium (ACYCLOVIR SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Acyclovir Sodium medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Acyclovir Sodium Injection is intended for intravenous infusion only, and should not be administered topically, intramuscularly, orally, subcutaneously, or in the eye. Intravenous infusions must be given over a period of at least 1 hour to reduce the risk of renal tubular damage (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ). Renal failure, in some cases resulting in death, has been obs

No black box warning on record for Acyclovir Sodium

Other warnings & precautions

WARNINGS Acyclovir Sodium Injection is intended for intravenous infusion only, and should not be administered topically, intramuscularly, orally, subcutaneously, or in the eye. Intravenous infusions must be given over a period of at least 1 hour to reduce the risk of renal tubular damage (see PRECAUTIONS and DOSAGE AND ADMINISTRATION ). Renal failure, in some cases resulting in death, has been obs

Acyclovir Sodium Black Box Warning

No black box warning on record for Acyclovir Sodium

Other warnings & precautions

Acyclovir Sodium Black Box Warning

No black box warning on record for Acyclovir Sodium

Other warnings & precautions